Polyrizon partners with Clearmind to develop intranasal MEAI formulation
Go back to Polyrizon partners with Clearmind to develop intranasal MEAI formulation| (NASDAQ: CMND) | Delayed: 0.97 -0.01 (1.02%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $0.98 | 52 Week High | $ | |||
| Open | $1.00 | 52 Week Low | $ | |||
| Day High | $1.06 | P/E | N/A | |||
| Day Low | $0.95 | EPS | $ | |||
| Volume | 288,315 | |||||
| (NASDAQ: PLRZ) | Delayed: 11.03 -0.2 (1.78%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $11.23 | 52 Week High | $ | |||
| Open | $11.19 | 52 Week Low | $ | |||
| Day High | $11.36 | P/E | N/A | |||
| Day Low | $10.50 | EPS | $ | |||
| Volume | 76,585 | |||||

